The Traderszone Network

Stocks ended with modest gains Monday after starting off the session in choppy fashion. Leading stocks acted well. The Nasdaq rose 0.4% to its highest close since March 28, 2000. It’s been trading sideways for about a week, pausing after surging 13% off its Oct. 15 low. Helped by the strength in transportation stocks, the S&P 500 climbed 0.3% to another record high. Transports are one sector that’s seeing a large number of new highs.

read more

NASH is a liver disease that may affect as much as 12 percent of the U.S. population, Genfit’s Dean Hum said.

The commodities upswing might be over, trader Dennis Gartman said.

Natural gas futures swung wildly before closing lower for the first time in 10 sessions, signalling a volatile winter ahead for the commodity.

Arrowhead Research Chief Executive Chris Anzalone contends the company’s hepatitis B drug has potential.

Orexigen Therapeutics is today’s best biotech stock after reporting its third-quarter earnings results and providing an update on its Contrave program. Find out if its shares can motor even higher.

read more

Craig Spencer, the New York City doctor who contracted Ebola, is being released from Bellevue, the NYT reports.